Patent US3847681A successfully refreshed from Google Patents.
Patent US3997660A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3997660A Expired / Lapsed US ⏱️ 0.0 years remaining

Soluble hydrophilic polymers and process for producing the same

Assignee: Czech Academy of Sciences
•
Filing: 1974-04-25
•
Granted: 1976-12-14
•
Expires: 1994-04-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Soluble, hydrophilic polymers suitable for medical use and as blood plasma substitutes comprising low molecular weight polymer derived from at least one monomer of an acrylamide type material or a mono-ester of an acrylic type acid and a glycol which is condensed with bifunctional compounds to form a condensation polymer having increased molecular weight and enzymatically cleavable cross-links. The hydrophilic polymer is produced by polymerizing the acrylamide type material or mono-ester mentioned above to form a low molecular weight polymer which is then condensed with a bifunctional compound to form a high molecular weight condensation polymer having enzymatically cleavable cross-links.

Inventors

  • 👤 Jinrich Kopecek
  • 👤 Jiri Vacik
  • 👤 Ladislav Sprincl

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 20:19
CPC Classifications
C; C08; C08L; C08L33/00; C08F; C08F20/00; C08F20/02; C08F20/52; C08F20/54; C08G; C08G18/00; C08G18/06; C08G18/28; C08G18/40; C08G18/62; C08G18/6216; C08G18/6266; C08G18/6283; C08L33/04; C08L33/14; Y; Y10; Y10S; Y10S424/00; Y10S424/13

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 179 words
A solution for use as a blood plasma substitute or cosmetic or medicinal carrier comprising, in a physiological saline solution, a water soluble low molecular weight polymer comprising the polymerizate of at least one monomer selected from the group consisting of N-alkyl methacrylamides, N-hydroxyalkyl methacrylamides, N-alkyl acrylamides, N-hydroxyalkyl acrylamides, N,N-dialkyl acrylamides, and mono-esters of acrylic and methacrylic acids with di-, tri- and higher homologous polyethlene glycols wherein the alkyl radicals are selected from the group consisting of unsubstituted and substituted alkyl radicals, the substituents being selected from the group consisting of hydroxy, amino and alkoxy groups, said low molecular weight polymer having an average molecular weight in a range of 10,000 to 60,000 and containing up to 1% maximum of a fraction having a molecular weight above 100,000, said low molecular weight polymer being condensed with at least one bifunctional compound selected from the group consisting of diisocyanates, halides of dicarboxylic acids, phosgene and dialdehydes derived from dicarboxylic acids to form a condensation polymer having a molecular weight in a range of 60,000, to 240,000 and having cleavable cross-links.
Claim 2
Dependent Claim 179 words
A solution for use as a blood plasma substitute or cosmetic or medicinal carrier comprising, in a physiological saline solution, a water soluble low molecular weight polymer comprising the polymerizate of at least one monomer selected from the group consisting of N-alkyl methacrylamides, N-hydroxyalkyl methacrylamides, N-alkyl acrylamides, N-hydroxyalkyl acrylamides, N,N-dialkyl acrylamides, and mono-esters of acrylic and methacrylic acids with di-, tri- and higher homologous polyethlene glycols wherein the alkyl radicals are selected from the group consisting of unsubstituted and substituted alkyl radicals, the substituents being selected from the group consisting of hydroxy, amino and alkoxy groups, said low molecular weight polymer having an average molecular weight in a range of 10,000 to 60,000 and containing up to 1% maximum of a fraction having a molecular weight above 100,000, said low molecular weight polymer being condensed with at least one bifunctional compound selected from the group consisting of diisocyanates, halides of dicarboxylic acids, phosgene and dialdehydes derived from dicarboxylic acids to form a condensation polymer having a molecular weight in a range of 60,000, to 240,000 and having cleavable cross-links.
Claim 3
Dependent Claim 11 words
The solution of claim 1 wherein said monomer is N-(2-hydroxy-propyl) methacrylamide.
Claim 4
Dependent Claim 19 words
The solution of claim 1, wherein said alkyl radicals of the monomer contains from one to three carbon atoms.
Claim 5
Dependent Claim 19 words
The solution of claim 1, wherein said hydroxy, amino and alkoxy substituents contain from one to six carbon atoms.
Claim 6
Dependent Claim 36 words
The solution of claim 1, wherein said alkyl radicals of the monomer contain from one to three carbon atoms and said alkyl radicals are substistuted alkyls wherein said substituents contain from one to six carbon atoms.

References Cited (Backward Citations)

US3086887A Cited
US3245941A Cited
US3415768A Cited
US3575946A Cited
DE2127288A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-12-14 1980-06-14 1980-12-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-12-14 1984-06-14 1984-12-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-12-14 1988-06-14 1988-12-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag